Temporal Interference Stimulation for Healthy Adults

(CAP-TI Trial)

SP
Overseen BySean Prahl
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is to find out whether a type of non-invasive electrical brain stimulation called temporal interference transcranial electrical stimulation (TI-TES) can temporarily change brain activity during sleep, especially sleep spindles (brain rhythms in the \~8-16 Hz range). Up to 24 healthy participants in Dane County, Wisconsin will be enrolled for 3 overnight study visits. Participants can expect to be on study for approximately 5 weeks, depending on scheduling availability.

Who Is on the Research Team?

LA

Larissa Albantakis, PhD

Principal Investigator

University of Wisconsin, Madison

Are You a Good Fit for This Trial?

Inclusion Criteria

* Medically healthy (based on self-report and study team review)
* U.S. citizen or holding permanent resident status
* English-speaking (able to provide consent and complete questionnaires)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Baseline Assessment

Participants complete a structural MRI for personalized montage optimization

1 week
1 visit (in-person)

Treatment

Participants undergo three overnight hdEEG and PSG sleep sessions with TI-TES delivered during NREM sleep

3 weeks
3 visits (overnight, in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Temporal Interference Stimulation

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: All ParticipantsExperimental Treatment5 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+